Ms. Callie Earliwine, Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 169 Sand Hill Rd, Dallas, WV 26036 Phone: 304-547-5041 |
News Archive
Because mice do not respond to immunomodulatory drugs, preclinical therapeutic and safety studies of the effects of IMiDs have not been possible in existing types of mice.
Recent state developments include the prominent place health care is taking in New Jersey's governor's race, criticism of a payment plan for hospitals in Massachusetts and the potential cost of lawsuits in California.
Endologix, Inc. developer of minimally invasive treatments for aortic disorders, announced today the first clinical implant of the Company's Ventana fenestrated stent graft at Auckland City Hospital in Auckland, New Zealand.
Nearly 50 percent of Medicaid patients infected with chronic hepatitis C whose doctors had prescribed newer, life-saving antiviral drugs were denied coverage to the therapies because they weren't considered "a medical necessity" or because the patients tested positive for alcohol/drugs, among other reasons, according to new Penn Medicine research.
Octapharma AG recently submitted its Biological License Application for octagam(R) 10% (human normal intravenous immunoglobulin, liquid) to the U.S. Food and Drug Administration (FDA) with the goal of expanding the biopharmaceutical company's U.S. immune globulin therapy portfolio by early 2010. The application was submitted for the treatment of Idiopathic Thrombocytopenic Purpura (ITP), a blood-clotting disorder that can result in excessive bruising and bleeding.
› Verified 6 days ago